Insiders IRLAB Therapeutics AB

Equities

IRLAB A

SE0012675361

Delayed Nasdaq Stockholm Other stock markets 02:51:34 15/05/2024 pm IST			5-day change	1st Jan Change
16.1 ^SEK	-0.62%		+40.00%	+114.67%

08/05	Transcript : IRLAB Therapeutics AB, Q1 2024 Earnings Call, May 08, 2024
07/05	IRLAB Therapeutics AB and McQuade Center for Strategic Research and Development, LLC Enter into Development Collaboration for IRL757 as Novel Treatment for Apathy	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

IRLAB Therapeutics AB Announces Appointment to its Nomination Committee	07/11	CI
IRLAB Therapeutics AB Elects Christer Nordstedt, Daniel Johnsson and Veronica Wallin as Board Members	20/23/20	CI
IRLAB Therapeutics AB Announces the Resignation of An Van Es-Johansson as Board Member	21/23/21	CI
Irlab Therapeutics AB Announces Board Changes	20/23/20	CI
Irlab Therapeutics AB Announces CEO Changes	20/23/20	CI
IRLAB Therapeutics AB Nominates IRL1117 as Drug Candidate from the P003 Project to Develop a Novel Treatment for Parkinson's Disease	12/23/12	CI
Nomination committee in IRLAB appointed ahead of annual general meeting 2023	15/22/15	AQ
IRLAB Therapeutics AB Appoints Nomination Committee Ahead of Annual General Meeting 2023	15/22/15	CI
IRLAB Therapeutics AB Appoints Richard Godfrey as CEO, Effective from 1 July 2022	10/22/10	CI
IRLAB Therapeutics AB Approves Board Appointments	11/22/11	CI
IRLAB Therapeutics AB Nominates New Candidate Drug, IRL757, to Treat Apathy in Neurological Disorders	21/22/21	CI
IRLAB Therapeutics AB Announces Board Changes	31/21/31	CI
Nomination committee in IRLAB appointed ahead of annual general meeting 2022	05/21/05	AQ
IRLAB Therapeutics AB Appoints Martin Nicklasson as New Director	06/21/06	CI
IRLAB Therapeutics : nomination committee proposes Martin Nicklasson as new board member and provides their proposal	08/21/08	AQ
IRLAB Therapeutics AB Announces Appointments of Members of Nomination Committee	30/20/30	CI
IRLAB Therapeutics : Nomination committee in IRLAB appointed ahead of annual general meeting 2021	30/20/30	AQ
IRLAB Therapeutics AB Announces No Dividend Payment for the Previous Financial Year; Elects Gunnar Olsson as New Chairman of the Board	07/20/07	CI
IRLAB Therapeutics AB Announces the Appointments to the Nomination Committee	17/19/17	CI
IRLAB Therapeutics AB Appoints Carola Lemne as Board Member and New Deputy Chairman of the Board	25/19/25	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders IRLAB Therapeutics AB

Equities

IRLAB A

SE0012675361

Insiders

Filters